Tag: ClinicalTrials

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

Bicycle Therapeutics Reports Interim BT8009 Phase I Clinical Trial Results

David Kim04/11/2022

17385

Bicycle Therapeutics Limited plc (NASDAQ: BCYC) reported interim Phase I results from the Phase I/II trial of BT8009, a second generation BTC that targets Nectin-4. Results were presented on...

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

Protalix BioTherapeutics and Chiese Global Rare Diseases Report Topline Results from the Phase III BALANCE Clinical Trial

David Kim04/04/2022

17426

Protalix BioTherapeutics Inc. (NYSE: PLX) has reported topline results from the BALANCE pivotal Phase III clinical trial evaluating pegunigalsidase alfa (PRX–102), 1 mg/kg, administered every two weeks. “We are pleased...

Tag: ClinicalTrials

Bicycle Therapeutics Reports Interim BT8009 Phase I Clinical Trial Results

Protalix BioTherapeutics and Chiese Global Rare Diseases Report Topline Results from the Phase III BALANCE Clinical Trial

ABOUT US

Tweets